Clinical Trials Logo

Clinical Trial Summary

In recent years, daytime operation has been developed gradually in China. Circumcision in children is a common type of daytime operation. The nature of the operation and the object of the operation determine that the anesthetic drugs used should induce fast, wake up quickly and recover in a high quality. Esketamine is an S-enantiomer of ketamine, which is newly marketed in China. Compared with ketamine, it has stronger effect on NMDA receptor, and its sedative effect is about twice as high. The occurrence frequency of respiratory depression and hypotension is lower than that of other anesthetics and analgesics, which can provide good analgesic and sedative effect for surgical anesthesia. In clinical practice, ketamine combined with sevoflurane has been widely used in children's microsurgery, but there has been no report on Esketamine combined with sevoflurane anesthesia. In order to find out the best combined dose, this paper compares the single administration of three different doses of esketamine combined with sevoflurane anesthesia in the circumcision of children.


Clinical Trial Description

To investigate the optimal dose of esketamine combined with sevoflurane for pediatric circumcision. Methods children who underwent day surgery of pediatric circumcision were randomly divided into 3 groups according to the random number table method:0.5mg/kg esketamine group (Group A), 0.75mg/kg esketamine group (Group B) and 1.0mg/kg of esketamine group (Group C), with 30 people in each group. mask inhalation of sevoflurane anesthesia, each group was given a single intravenous dose of the corresponding esketamine. Heart rate (HR), mean arterial pressure (MAP), pulse oxygen saturation (SpO2) and respiratory rate (RR) were recorded at room entry (T0), intravenous ketamine administration (T1), operation initiation (T2), intraoperative central ligation (T3) and operation completion (T4).The number and total amount of ketamine added intraoperatively were recorded. Duration of operation, time to open eyes and time to answer were recorded. The Eastern Ontario Children's Hospital pain Score (CHEOPS score) and the modified Bieri pain score were recorded when awake, 2 hours and 6 hours postoperatie. MOAA/S score was recorded at 15, 30 and 60min after surgery. Intraoperative and post-operative adverse reactions were recorded, including hypersensitivity, agitation, nausea and vomiting, dizziness, diplopia, etc. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04698434
Study type Interventional
Source Yangzhou University
Contact
Status Completed
Phase N/A
Start date January 15, 2021
Completion date March 30, 2021

See also
  Status Clinical Trial Phase
Recruiting NCT01108198 - Treatment of Phimosis With Topical Steroid Cream -Double-blind, Randomized, Placebo-controlled Study Phase 4
Recruiting NCT04646967 - An Evaluation of Pain Outcomes of Ketorolac Administration in Children Undergoing Circumcision Phase 2
Completed NCT01794221 - The Role of 2-octyl Cyanoacrylate in Prevention of Recurrent Adhesions After Circumcision N/A
Withdrawn NCT01483313 - Intelligence Changes Following Minor Surgery N/A
Recruiting NCT04902898 - Safety and Efficacy of the Sterile Single-use Circular Stapling Device CIRCCURER II (Jiangxi Langhe Medical Instrument Co., Ltd., Guangzhou, China) N/A
Suspended NCT05708989 - Caudal vs. Pudendal Block in Peds GU Phase 4
Completed NCT04755803 - A Prospective Registry of Patients With Congenital Penile Anomalies
Completed NCT02973958 - Evaluating Pain Outcomes of Ketorolac Administration in Children Undergoing Circumcision Phase 1
Withdrawn NCT00933023 - Mild Versus Potent Corticosteroids as Treatment for Phimosis in Children Phase 4
Recruiting NCT03931850 - Does Neurostimulation Improve Efficacy for Ultrasound-Guided Transperineal Pudendal Nerve Block In Children N/A